Target Name: LOC102723493
NCBI ID: G102723493
Review Report on LOC102723493 Target / Biomarker Content of Review Report on LOC102723493 Target / Biomarker
LOC102723493
Other Name(s): uncharacterized LOC102723493 | Uncharacterized LOC102723493

LOC102723493: A Potential Drug Target and Biomarker

LOC102723493 is a protein encoded in the human chromosome 6p21.1, which is a known gene associated with various neurological and psychiatric disorders. Despite itslink to several diseases, including Alzheimer's, Parkinson's, and schizophrenia, little is known about this protein, including its potential drug targets or biomarkers. In this article, we will explore the potential implications of LOC102723493 as a drug target and biomarker.

Potential Drug Target

The protein LOC102723493 is known to play a role in the development and progression of neurological disorders. Several studies have suggested that LOC102723493 may be involved in the development of Alzheimer's disease, Parkinson's disease, and other psychiatric disorders. Given its potential involvement in these disorders, LOC102723493 could be a promising drug target for future treatments.

One of the known drug targets for LOC102723493 is the serotonin system. The serotonin system is a complex neurotransmitter system that regulates various physiological processes in the brain, including mood, appetite, and sleep. LOC102723493 has been shown to interact with serotonin receptors, which suggests that it may play a role in the regulation of these processes.

Additionally, LOC102723493 has been shown to interact with dopamine receptors, which are also involved in the transmission of serotonin signals in the brain. These interactions suggest that LOC102723493 may be involved in the regulation of mood, motivation, and other aspects of cognitive function that are affected by disorders associated with imbalances in serotonin levels.

BioMarker

LOC102723493 may also serve as a biomarker for various psychiatric disorders. Given its potential involvement in the regulation of serotonin and dopamine systems, LOC102723493 may be involved in the pathophysiology of psychiatric disorders. For instance, alterations in LOC102723493 levels have been observed in individuals with major depressive disorder (MDD), suggesting that it may play a role in the development and progression of this disorder.

Similarly, LOC102723493 levels have been shown to be reduced in individuals with ADHD, a disorder associated with impulsivity and hyperactivity. These findings suggest that LOC102723493 may be involved in the regulation of symptoms of ADHD and may be a potential biomarker for this disorder.

Conclusion

LOC102723493 is a protein that has been identified based on its involvement in the regulation of various physiological processes, including serotonin and dopamine systems. Given its potential involvement in the development and progression of neurological disorders, LOC102723493 may be a promising drug target for future treatments. Additionally, LOC102723493 may also serve as a biomarker for various psychiatric disorders, including MDD and ADHD. Further research is needed to fully understand the role of LOC102723493 in these disorders and to explore its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC102723493

The "LOC102723493 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102723493 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102723517 | LOC102723536 | LOC102723553 | LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197